Ben Stephens

Ben Stephens is an accomplished executive with extensive experience in financial leadership and operations across various sectors, primarily within biotechnology and therapeutic development. Currently serving as Chief Operating Officer at Sitryx and Financial Director at both Rinri Therapeutics and Vianautis, Ben has a profound understanding of immunometabolism and regenerative cell therapy. Previous roles include Chief Financial Officer at Dark Blue Therapeutics, Head of Finance at Parapharm Development Limited, and Finance Director at Altacor Limited, where expertise in financing and operational management has been demonstrated. An entrepreneur as the owner of Forstep Ltd, Ben also has a diverse background including a stint as Managing Director of an online wine business. Educational qualifications include a Bachelor of Science in Management Sciences from the University of Warwick and a diploma in Wines and Spirits.